[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Anders_Research Avatar @Anders_Research Anders Research

Anders Research posts on X about $stim, $airs, $notv, $aclx the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXX% stocks XXXX% currencies XXXX%

Social topic influence $stim #3, $airs #2, $notv #1, $aclx #8, strong 5.71%, $capr #12, glad #594, $qcls #16, shell #664, $immx #8

Top accounts mentioned or mentioned by @badvalla40301 @bowtiedbiotech @longroaderstar @martinshkreli @zubicnemanja @idalopirdine @saicharanaitha @andre_agtc @dnobel22 @genejchan @adamfeuerstein @realdonaldtrump @txmctrades @lawrencelepard @commonsenseplay @citrini7 @edwardjjiang @ryansttrader @doodaddoctor @nikki3958140800

Top assets mentioned Arcellx, Inc. Common Stock (ACLX) Janux Therapeutics, Inc. Common Stock (JANX) IonQ, Inc. (IONQ) Rigetti Computing, Inc. Common Stock (RGTI) D-Wave Quantum Inc. (QBTS) Bitcoin Incognito (XBI) ImmunityBio, Inc. Common Stock (IBRX) Prothena Corporation plc Ordinary Shares (PRTA) AstraZeneca PLC (AZN)

Top Social Posts

Top posts by engagements in the last XX hours

"Citrini eating the $JANX flop after he increased it to a XX% weighting in his biotech portfolio last week (#1 holding). To be fair he laid out the risk. Just highlights how difficult biotech picking is especially if you are already spread thin"
X Link 2025-12-02T01:07Z 3786 followers, 15.4K engagements

"$MAIA with a rough go recently and unlikely to stop. Example of the biotech financing doom loop. Has interesting data but not quite at level where it has been able to convinced fund larger trials. Lack of catalysts begets lack of capital which begets lack of catalysts"
X Link 2025-11-19T23:03Z 3780 followers, XXX engagements

"ASH abstract from Kelonia Therapeutics' in-vivo BCMA CAR T that is causing $ACLX to dip XX% intraday. In-vivo CAR T assuming they come to fruition are vastly superior to current CAR Ts. No wonder J&J partnered up with Kelonia earlier this month"
X Link 2025-11-24T18:54Z 3782 followers, 6639 engagements

"Was a bit nervous that we could see some worsening at X months but $GUTS OL results continue to validate Revita. If the pbo-controlled cohort performs similarly the disparity on the graph will be quite striking (placebo regained XX% at X months). Catalysts still strong"
X Link 2025-12-02T16:51Z 3782 followers, 5305 engagements

"Says the account is no big deal started with $30k went to $260k then zero. Basically says you guys (those complaining in the chat) seem to care more about it than I do Maybe they care about heir own money (Nevermind that the $30k is completely unverifiable and he talked a lot about adding capital to cover/short more quantum etc.)"
X Link 2025-12-04T16:26Z 3779 followers, 40K engagements

"Pretty good week going for $IVVD Did $PALI remind people that it is kind of a big deal that Point72 took an X% stake in $IVVD"
X Link 2025-10-09T19:01Z 3785 followers, 3499 engagements

"Citrini chat been in absolute shambles since yesterday after revealing he sold long-promoted/supported micro-cap MedTech names without explanation. These people (a lot of them appear to be beginner/retail/casuals) are PISSED. 🧵 Names include $STIM $AIRS $NOTV"
X Link 2025-11-18T16:26Z 3786 followers, 139.7K engagements

"Some interesting angles on $VTGN. Comparison of Q2 vs. Q3 8-K showing softer language regarding regulatory pathway is interesting. Data to date are all over the place. Still the part of my brain that has led me astray before feels like this uber-controlled trial could hit"
X Link 2025-12-03T03:55Z 3786 followers, 2449 engagements

"LOL Shkreli account completely wiped out by $CAPR Says hes sorry if anybody joined me on that He also wants you to know that: 1) Its no big deal (for him) 2) He is glad the account blew up 3) $QCLS a nano-cap quantum-adjacent shell co he is advising is the next move. 🧵"
X Link 2025-12-04T16:26Z 3786 followers, 436.4K engagements

"Is there any chance that the reason all of the quantum stocks are up big the past two days is because Shkreli had to unwind his shorts due to $CAPR loss $RGTI $QBTS $IONQ all up double digits today after a big day yesterday. Probably nothing"
X Link 2025-12-04T19:11Z 3786 followers, 15.4K engagements

"Mid-cap value manager talking to a generalist manager last night: "And even the smaller biopharma names are interesting I've been poking around there." Nevermind that he eventually told me he is looking at $ANVS. The generalists are coming"
X Link 2025-11-21T17:31Z 3776 followers, 1208 engagements

"@Citrini7 @edwardjjiang Fair enough though I would point out $XBI is up XX% over the past X months and $BBC which seems to be a closer comparator to this basket is up 91%"
X Link 2025-12-02T15:10Z 3779 followers, XXX engagements

"@idalopirdine @MartinShkreli Yes most know what they are getting into though there were definitely a fair number of precious lambs sacrificed yesterday. Its on them lesson learned"
X Link 2025-12-04T19:40Z 3776 followers, 4728 engagements

"Interesting this Kelonia abstract is only affecting $ACLX and not $KYTX $CABA and even $IMMX. Probably because $KYTX $CABA and $IMMX are tiny and will have time to capture value. In-vivo a long-term overhang for all CAR Ts including $IMMX"
X Link 2025-11-24T19:31Z 3786 followers, 2416 engagements

"Looks like $IBRX gonna keep going up this coming week. Lots of random accounts tweeting about it all of the sudden. Maybe just my feed but feels like it is really catching on with retail. Correcting lymphopenia is easy to understand and Dr. Soon-Shiong is a good promoter"
X Link 2025-11-29T23:34Z 3786 followers, 3229 engagements

"$IMMX premarket signaling another up day coming. Stock is in the midst of a dramatic re-rating after being overlooked and ignored for a long time. Should easily reach $700+ million of peak sales versus $400M current MC ($300M EV)"
X Link 2025-12-10T14:11Z 3786 followers, 1803 engagements

"$DRTS up +13%. Presented at Sidoti today. Highlighted first patient dosed in GBM approval for a prostate trial strong enrollment in pancreatic continued strong relationship with the FDA etc. Still only $400M MC with potential to treat most solid tumor types"
X Link 2025-12-10T17:54Z 3786 followers, XXX engagements